Back

VJHemOnc is committed to improving our service to you

iwNHL 2015 | iwNHL 2015 roundtable: Day 2 highlights – CAR T-cell therapy for non-Hodgkin lymphoma

VJHemOnc is committed to improving our service to you

John Gribben and Wyndham Wilson

John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, chairs a discussion with Wyndham Wilson, MD, PhD, of the National Cancer Institute, Bethesda, MD, on the highlights from the second day of the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting. They explain the challenges, including the need to overcome clinical toxicities, to chimeric antigen receptor (CAR)-T cell therapy for the treatment of patients with non-Hodgkin lymphoma.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter